Showing results (241-250 of 305) with videos related to
Sort By:
Pageof 31
Kidney International|January 3, 2001
Hypoalbuminemia and proteinuria contribute separately to reduced lipoprotein catabolism in the nephrotic syndromeG C Shearer, F T Stevenson, D N Atkinson, et al.The Journal of Biological Chemistry|August 4, 2006
No change in glomerular heparan sulfate structure in early human and experimental diabetic nephropathyJacob van den Born, Brenda Pisa, Marinka A H Bakker, et al.Bioscience Reports|October 1, 1985
Preparation and properties of FabIgG, a chimeric univalent antibody designed to attack tumour cellsG T Stevenson, M J Glennie, F E Paul, et al.The Journal of Biological Chemistry|August 15, 1998
A novel carbohydrate-glycosphingolipid interaction between a beta-(1-3)-glucan immunomodulator, PGG-glucan, and lactosylceramide of human leukocytesJ W Zimmerman, J Lindermuth, P A Fish, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|February 14, 1998
Greater rate of decline in maximal aerobic capacity with age in physically active vs. sedentary healthy womenH Tanaka, C A Desouza, P P Jones, et al.Blood|December 1, 1988
Lymphokine-activated killer cells from normal and lymphoma subjects are cytotoxic for cells coated with antibody derivatives displaying human Fc gammaR J Dearman, F K Stevenson, M Wrightham, et al.Brain Research|September 2, 2017
The effect of type of afferent feedback timed with motor imagery on the induction of cortical plasticityN Mrachacz-Kersting, M Voigt, A J T Stevenson, et al.Molecular Immunology|November 1, 1991
Characterization of a new monoclonal anti-Fc gamma RII antibody, AT10, and its incorporation into a bispecific F(ab')2 derivative for recruitment of cytotoxic effectorsJ Greenman, A L Tutt, A J George, et al.Aviation, Space, and Environmental Medicine|May 20, 2014
Blood pressure, vascular resistance, and +Gz tolerance during repeated +Gz exposuresAlec T Stevenson, Jonathan P R Scott, Scott Chiesa, et al.Diabetologia|October 31, 2009
Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) studyE Ritz, G C Viberti, L M Ruilope, et al.Pageof 31